Nutriband Inc.
NTRB
$3.53
$0.000.00%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/22/2026
-
The Cerbat Gem
5/15/2026
-
Globe Newswire
4/22/2026
-
Globe Newswire
4/20/2026
-
MarketBeat
4/15/2026
-
Zolmax
4/6/2026
-
TipRanks Financial Blog
3/30/2026
-
Globe Newswire
3/18/2026
-
TipRanks Financial Blog
3/18/2026
-
The Fly
3/18/2026
-
Globe Newswire
3/4/2026
-
MarketBeat
2/17/2026
-
Globe Newswire
2/17/2026
-
The Fly
2/17/2026
-
Globe Newswire
2/13/2026
-
TipRanks Financial Blog
2/11/2026
-
MarketBeat
1/30/2026
-
The Fly
1/30/2026
-
Globe Newswire
1/1/2026
-
MarketBeat
12/31/2025
-
GuruFocus
12/31/2025
-
The Fly
12/31/2025
-
GuruFocus
12/31/2025
-
Globe Newswire
12/30/2025
-
TipRanks Financial Blog
12/30/2025
-
Simply Wall St
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, April 29, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 25 and 29 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
407 377 6695
Address
121 South Orange Avenue
Orlando, FL 32801
Orlando, FL 32801
Country
Year Founded
Business Description
Sector
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of...
more